
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
Essential steps to help health systems better prepare for disruptions.
Date
February 14, 2022
By: McKesson MedSurg Editorial Team
Read time: 5 minutes
There are important differences between biosimilars and biologics. research and studies show that the use of biosimilar drugs can save money for both patients and providers, and increased affordability of biosimilars can have a meaningful impact on the healthcare system.
To dive deeper into the differences, examining the costs and benefits, Derek Burns and Tim Ho, clinical specialists at McKesson, share their insights on biosimilars and discuss their expert knowledge of these new products.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
Discover three key takeaways from a recent C-suite roundtable discussing the benefits and challenges of central fill for health systems.
Industry event highlights how connection, creativity, and a fresh perspective are shaping the future of health system innovation.
An exclusive introduction to our newest services and solutions designed to help forward-thinking health systems modernize their specialty and infusion strategies.
Drug shortages have decreased, but supply chain complexity requires ongoing innovation and resilience to maintain drug availability.